Press release
Neurostem, LLC Opens in Shreveport, Bringing Advanced TMS Therapy to Northwest Louisiana
Doctor prepping patient for TMS treatment.
Transcranial Magnetic Stimulation (TMS) uses focused magnetic pulses delivered through a coil placed against the scalp to influence the brain's natural electrical activity. This scientifically supported, non-invasive and drug-free therapy has shown effectiveness for major depressive disorder (particularly cases where other treatments have failed), obsessive-compulsive disorder (OCD), migraine headache relief, certain anxiety disorders, and smoking cessation support.
"At Neurostem, we believe in providing advanced neurotherapy with compassionate, evidence-based care," said Dr. Trevor Peck, Medical Director at Neurostem, LLC. "TMS has transformed the treatment landscape for many patients, but access has been limited. Our clinic brings physician-led TMS care to Shreveport and the surrounding area, ensuring patients receive this life-changing option with proper medical oversight."
Key Features of the Neurostem TMS Program:
Physician-Supervised Treatment: All TMS sessions are conducted under the direct guidance of licensed doctors or trained clinical specialists to ensure safety, personalized protocols, and optimal outcomes.
Customized Care Plans: Every patient undergoes a comprehensive initial consultation, and treatment protocols are tailored to individual needs and goals.
Insurance Support: Neurostem accepts most major insurance plans. Staff verify coverage prior to the first treatment to help streamline the process.
Broad Therapeutic Applications: Beyond depression, TMS may benefit patients dealing with OCD, migraines, certain anxiety disorders, and more.
Neurostem, LLC is currently accepting advance appointments. Patients interested in learning more or joining the clinic's waiting list can call (318) 227-4088, email admin@neurostemllc.com, or visit neurostemllc.com
Neurostem, LLC
ATTN: Kathryn Thomas
745 Olive Street, Suite 202
Shreveport, LA 71104
About Neurostem, LLC Neurostem, LLC is a Shreveport-based clinic dedicated to offering high-quality Transcranial Magnetic Stimulation (TMS) therapy. With a focus on innovative, non-invasive treatment options and patient-centered care, Neurostem aims to expand access to advanced neurological therapies that improve quality of life for individuals with complex conditions. All treatments are provided under the supervision of qualified physicians in a compassionate clinical setting.
FOR IMMEDIATE RELEASE
Contact: Neurostem, LLC 745 Olive Street, Suite 202 Shreveport, LA 71104 Phone: (318) 227-4088 Email: admin@neurostemllc.com Website: https://neurostemllc.com/
###
For additional information, interviews, or images, please contact Kathryn Thomas, Neurostem, LLC partner, at (318) 227-4088 or email admin@neurostemllc.com.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurostem, LLC Opens in Shreveport, Bringing Advanced TMS Therapy to Northwest Louisiana here
News-ID: 4338127 • Views: …
More Releases for TMS
Neuralia TMS Broadens Access to Non-Invasive TMS Treatment for Depression
Australia, 27th Jan 2026 - Neuralia TMS, a respected provider of non-invasive neuromodulation therapies, has announced an expansion of access to Transcranial Magnetic Stimulation treatment for individuals living with depression, reflecting continued developments in evidence-based mental health care and increasing demand for non-pharmacological treatment options. The expanded availability is intended to support patients seeking additional clinical pathways under medical supervision.
Transcranial Magnetic Stimulation, commonly known as TMS, is a non-invasive procedure…
Neuralia TMS Broadens Access to Non-Invasive TMS Treatment for Depression
Australia, 27th Jan 2026 - Neuralia TMS, a respected provider of non-invasive neuromodulation therapies, has announced an expansion of access to Transcranial Magnetic Stimulation treatment for individuals living with depression, reflecting continued developments in evidence-based mental health care and increasing demand for non-pharmacological treatment options. The expanded availability is intended to support patients seeking additional clinical pathways under medical supervision.
Transcranial Magnetic Stimulation, commonly known as TMS, is a non-invasive procedure…
Neuralia TMS Opens Doors in Melbourne to Meet Rising Demand for TMS Treatment Ac …
Australia, 17th Dec 2025 - Neuralia TMS, a leader in Transcranial Magnetic Stimulation (TMS) therapy, has officially opened a new clinic in Moonee Ponds to address the increasing demand for alternative treatments for mental health and chronic pain. The new facility offers non-invasive TMS therapy to treat conditions such as depression, anxiety, and chronic pain by using magnetic pulses to stimulate specific areas of the brain, providing patients with an…
Neuralia TMS Provides Proven TMS Therapy to Help Manage Depression
Australia, 19th Nov 2025 - Neuralia TMS, a respected provider of neuromodulation treatments in Melbourne's inner north, has reaffirmed its commitment to delivering evidence-supported Transcranial Magnetic Stimulation (TMS) therapy for individuals experiencing treatment-resistant depression. The clinic, located at Suite 102/149-155 Pascoe Vale Rd, Moonee Ponds 3039 VIC, continues to operate as a treatment centre offering structured, non-invasive therapeutic programs grounded in current clinical research.
TMS therapy has become an established component…
TMS (Transcranial Magnetic Stimulation) Coil Market Analysis By Manufacturers - …
The TMS (Transcranial Magnetic Stimulation) Coil Market Research Report Forecasts 2019-2025 is a valuable source of insightful data for business strategists. This TMS (Transcranial Magnetic Stimulation) Coil Market study provides comprehensive data on aspects of competitive intelligence, market research, strategy, planning, pricing and forecasting that enhances the understanding, scope, and application of this report.
According to this study, over the next five years, the TMS (Transcranial Magnetic Stimulation) Coil market will…
TMS celebrates 50 not out
Dubai, 15th June 2016:- This is the 50th edition of the TMS Newsletter and The Maritime Standard would like to thank all its readers for their support in helping reach this significant milestone.
Clive Woodbridge, editor, says, “We are very grateful for the encouragement and positive feedback that our readers have given us. It is our aim to continue to improve the newsletter and we look forward to expanding and enhancing…
